Aveo Pharmaceuticals to pay U.S. SEC $4 mln to settle kidney drug case

(Reuters) - Biotech company Aveo Pharmaceuticals Inc will pay $4 million to settle civil charges that it misled investors about U.S. regulators' concerns involving its drug to treat kidney cancer, the Securities and Exchange Commission said on Tuesday.

http://ift.tt/xePdMM

from Reuters: Health News
via animenewspro